About — Ligase BioPartners

Our investment strategy

Ligase BioPartners creates and invests in the most innovative companies with an aim to advance science, promote healthcare sustainability and reduce disease burden.

Durable therapies

We prioritise scientific approaches designed to deliver lasting benefit — therapies or diagnostics that meaningfully change disease trajectories.

Accessible therapies

Accessibility by design: development and operating choices that enable scalable manufacturing, decentralisation, equitable distribution, and real-world adoption.

Unmet need

We focus on areas where clinical need remains profound, serving real-world patient populations with limited therapeutic options.

Embedded in the ecosystem

We maintain a special relationship with Oncode Institute and partner institutions in the Netherlands, and support founding teams through hands-on company building.

A differentiated network

We are embedded in the Dutch oncology and life sciences ecosystem through a close relationship with Oncode Institute and its partner institutions.

Beyond capital, we work side-by-side with founders together with experienced Entrepreneurs-in-Residence, supporting company formation and execution from the earliest stage.